Meeting Details

The 41st Annual General Meeting will be held on Thursday, 13th August, 2026 at 11:00 A.M. through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) in compliance with MCA circulars permitting virtual AGMs until September 30, 2026.

Ordinary Business Agenda

Item 1: Adoption of Financial Statements

To receive, consider and adopt the audited financial statements for the financial year 2025-26 along with reports of Board of Directors and Auditors.

Item 2: Reappointment of Director

To appoint Mr. Deniis Desai (DIN: 02904192), Whole-time director, who retires by rotation under Section 152(6) of Companies Act, 2013. He offers himself for reappointment.

Item 3: Appointment of Statutory Auditors

Special Resolution to appoint M/s. Natvarlal Vepari & Co., Chartered Accountants (Firm Registration no. 123626W) as Statutory Auditors from conclusion of 41st AGM till conclusion of 46th AGM (Financial Year 2030-31). Remuneration to be fixed by Board in consultation with auditors.

  • Proposed fees for FY 2026-27: ₹60,000
  • Retiring auditor: M/s. SVP & Associates, Chartered Accountants (Firm Registration Number: 003838N) completing term at this AGM
  • New auditor confirmed they meet eligibility criteria under Sections 139(2) and 141 of Companies Act, 2013
  • Auditor holds valid peer review certificate from ICAI

Special Business Agenda

Item 4: Appointment of Independent Director

Special Resolution to appoint Mrs. Sangita Hiren Shukla (DIN: 11647378) as Independent Director for 5 years from May 18, 2026 to May 17, 2031.

  • Originally appointed as Additional Director (Independent) effective May 18, 2026
  • Qualifications: Ph.D. in Pharmaceutical Sciences, MBA in HR, Master's in Pharmacy (Herbal Drug Technology)
  • 20+ years experience in pharmaceutical education and institutional management
  • Provided necessary declarations and consent forms (DIR-2, DIR-8)
  • No remuneration proposed (sitting fees not included)

Item 5: Loans, Investments, Guarantees under Section 186

Special Resolution to authorize Board for loans, guarantees, securities, and investments up to ₹100,00,00,000 (One Hundred Crores) outstanding at any time, exceeding normal limits under Section 186(2).

  • Current loans and investments within statutory limits
  • Authorization sought for greater financial flexibility

Item 6: Loans and Advances under Section 185

Special Resolution to authorize Board to advance loans, give guarantees, or provide security to entities where directors are interested, up to ₹50,00,00,000 (Fifty Crores) aggregate limit.

  • Loans must be utilized by borrowing company for principal business activities
  • Board to determine interest rates and terms

Voting Arrangements

  • Record date for voting: Thursday, August 6, 2026
  • Remote e-voting period: Monday, August 10, 2026 (9:00 AM) to Wednesday, August 12, 2026 (5:00 PM)
  • E-voting service provider: M/s. MUFG Intime India Pvt Ltd (formerly Link Intime India Pvt Ltd)
  • Scrutinizer: Mr. Ranjit Binod Kejriwal, Company Secretary (CP No. 5985)
  • Detailed voting instructions provided for shareholders in both demat and physical mode
  • Physical attendance dispensed with; no proxy facility available

Director Details for Reappointment

Mr. Deniis Desai (DIN: 02904192)

  • Date of Birth: 30-10-1980
  • Qualification: Master of Management Studies
  • Experience: 18+ years as strategic advisor in real estate and education
  • First appointed: 30/12/2025
  • Remuneration proposed: ₹5,00,000 per month
  • Current shareholding in company: 1,71,493 shares
  • Board meetings attended: 4 out of 4
  • Holds directorships in 6 other companies including Devinsu Trading Limited

Mrs. Sangita Hiren Shukla (DIN: 11647378)

  • Date of Birth: 24-05-1973
  • Qualification: Ph.D. (Pharmaceutical Sciences), MBA (HR), Master's in Pharmacy
  • Experience: 20+ years in pharmaceutical education and administration
  • First appointed: 18/05/2026
  • No remuneration proposed
  • No other directorships

Additional Information

  • Explanatory statement pursuant to Section 102 of Companies Act, 2013 provided for items 3-6
  • All documents available for inspection at registered office during business hours
  • Notice and annual report available on company website (www.devinsutrading.com), BSE website, and MUFG Intime website
  • Company registered office: 2, Floor-1, Plot-90/94, Zaveri Mansion, Shaikh Memon Street, Zaveri Bazar, Kalbadevi, Mumbai, Maharashtra, 400002
  • Equity shares under compulsory demat trading